DGEM guidelines enteral nutrition: Oncology;DGEM-leitlinie enterale ernährung: Onkologie

Aktuelle Ernahrungsmedizin

Volumn 28, Issue SUPPL. 1, 2003, Pages

  Arends, J ^a   Zurcher G ^b   Fietkau, R ^c   Aulbert, E ^d   Frick, B ^b   Holm, M ^e   Kneba, M ^f   Mestrom, H J ^g   Zander, A ^h  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

^d Inn Abt Ev Waldkrankenhaus S   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g Klinik Bergisch Land   (Germany)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cachexia; Complications; Enteral nutrition; Malnutrition; Oncology

Indexed keywords

CACHEXIA; CANCER THERAPY; CLINICAL FEATURE; ENTERIC FEEDING; HUMAN; MALNUTRITION; MEDICAL PRACTICE; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; TREATMENT INDICATION;

EID: 0037283098     PISSN: 03410501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Pichard C, Kyle UG. Body composition measurements during wasting diseases. Clin Nutr Metab Care 1998; 1: 357-361
2. ASPEN Board of Directors, Clinical Guidelines Task Force. Specific guidelines for disease - adults: cancer. JPEN 2002; 26: 82SA-83SA
3. Blackburn GL, Bistrian BR, Maini BR, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. JPEN 1977; 1: 11-22
4. Detsky AS, McLaughlin JR, Baker JP et al. What is Subjective Global Assessment of Nutritional Status? JPEN 1987; 11: 8-13
5. Dwyer JT. Dietary Assessment. In: Shils ME, Olson JA, Shike M (eds): Modern nutrition in health and disease. Philadelphia: Lea & Febiger, 1994: 842-860
6. Hackl JM, Balogh D. Indikation zur künstlichen Ernährung - was ist gesichert? Akt Ernährungsmed 1997; 22: 146-153
7. Arbeitsgemeinschaft für Klinische Ernährung. Empfehlungen für die parenterale und enterale Ernährungstherapie des Erwachsenen. 2000
8. Ollenschläger G, Konkol K, Mödder B. Indications for and results of nutritional therapy in cancer patients. Recent Results Cancer Res 1988; 108: 172-184
9. van Hoof P, Buill-Haasen M, Rouflart N, Soeters PB, von Meyenfeldt MF. Anorexia, malnutrition and food aversion with newly detected gastric or colorectal cancer. Clin Nutr 1989; 8: 151
10. DGE, ÖGE, SGE, SVE. Referenzwerte für die Nährstoffzufuhr. Frankfurt am Main: Umschau Braus, 2000
11. DeWys WD, Begg C, Lavin PT et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980; 69: 491-497
12. Chute CG, Greenberg ER, Baron J, Korson R, Baker J, Yates J. Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont. Cancer 1985; 56: 2107-2111
13. Wigmore SJ, Plester CE, Richardson RA, Fearon KCH. Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 1997; 75: 106-109
14. Andreyev HJN, Norman AR, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998; 34: 503-509
15. Costa G, Donaldson SS. Current concepts in cancer. N Engl J Med 1979; 300: 1471-1473
16. McAnena OJ, Daly JM. Impact of antitumor therapy on nutrition. Surg Clin North Am 1986; 66: 1213-1228
17. Knox LS, Crosby LO, Feurer ID, Buzby GP, Miller CL, Mullen JL. Energy expenditure in malnourished cancer patients. Ann Surg 1983; 197: 152-161
18. Dempsey DT, Feurer ID, Knox LS, Crosby LO, Buzby GP, Mullen JL. Energy expenditure in malnourished gastrointestinal cancer patients. Cancer 1984; 53: 1265-1273
19. Dempsey DT, Knox LS, Mullen JL, Miller CL, Feurer ID, Buzby GP. Energy expenditure in malnourished patients with colorectal cancer. Arch Surg 1986; 121: 789-795
20. Moldawer LL, Copeland EM. Proinflammatory cytokines, nutritional support, and the cachexia syndrom. Cancer 1997; 79: 1828-1839
21. de Blaauw I, Deutz NEP, von Meyenfeldt MF. Metabolic changes in cancer cachexia - first of two parts. Clin Nutr 1997; 16: 169-176
22. de Blaauw I, Deutz NEP, von Meyenfeldt MF. Metabolic changes of cancer cachexia - second of two parts. Clin Nutr 1997; 16: 223-228
23. Inui A. Cancer anorexia-cachexia syndrome: Are neuropeptides the key? Cancer Res 1999; 59: 4493-4501
24. von Meyenfeldt MF. Nutritional support during treatment of biliopancreatic malignancy. Ann Oncol 1999; 10: 273-277
25. Fearon KCH, Barber MD, Falconer JS, McMillan DC, Ross JA, Preston T. Pancreatic cancer as a model: Inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg 1999; 23: 584-588
26. Fordy C, Glover C, Henderson DC, Summerbell C, Wharton R, Allen-Mersh TG. Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver metastases. Br J Surg 1999; 86: 639-644
27. Simons JPFHA, Schols AM, Buurman WA, Wouters EF. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci 1999; 97: 215-223
28. Espat NJ, Moldawer LL, Copeland EM. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. J Surg Oncol 1995; 58: 77-82
29. Martin F, Santolaria F, Batista N et al. Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine 1999; 11: 80-86
30. O'Gorman P, McMillan DC, McArdle CS. Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer 2000; 37: 36-40
31. Lundholm K, Holm G, Schersten T. Insulin resistance in patients with cancer. Cancer Res 1978; 38: 4665-4670
32. Starnes HF, Warren RS, Brennan MF. Protein synthesis in hepatocytes isolated from patients with gastrointestinal malignancy. J Clin Invest 1987; 80: 1384-1390
33. Shaw JHF, Wolfe RR. Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. Ann Surg 1997; 205: 368-376
34. Zuijdgeest-van Leeuwen SD, van den Berg JWO, Wattimena JLD et al. Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects. Metabolism 2000; 49: 931-936
35. Körber J, Pricelius S, Heidrich M, Müller MJ. Increased lipid utilization in weight losing and weight stable cancer patients with normal body weight. Eur J Clin Nutr 1999; 53: 740-745
36. Barber MD, McMillan DC, Preston T, Ross JA, Fearon KCH. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci 2000; 98: 389-399
37. Legaspi A, Jeevanandam M, Starnes HF Jr, Brennan MF. Whole body lipid and energy metabolism in the cancer patient. Metabolism 1987; 36: 958-963
38. Jeevanandam M, Horowitz GD, Lowry SF, Brennan MF. Cancer cachexia and protein metabolism. Lancet 1984; 1: 1424-1426
39. Williams A, Sun X, Fischer JF, Hasselgren PO. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. Surgery 1999; 126: 744-750
40. Bossola M, Muscaritoli M, Costelli P et al. Increased muscle ubiquitin mRNA levels in gastric cancer patients. Am J Physiol Regulatory Integrative Comp Physiol 2001; 280: R1518-R1523
41. Tisdale MJ. Protein loss in cancer cachexia. Science 2000; 289: 2293-2294
42. Cabal-Manzano R, Bhargava P, Torres-Duarte A, Marshall J, Bhargava P, Wainer IW. Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss. Br J Cancer 2001; 84: 1599-1601
43. Tubiana M, Attié E, Flamant R, Gérard-Marchant R, Hayat M. Prognostic factors in 454 cases of Hodgkin's Disease. Cancer Res 1971; 31: 1801-1810
44. Swenerton KD, Legha SS, Smith T et al. Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 1979; 39: 1552-1562
45. van Eys J. Effect of nutritional status on response to therapy. Cancer Res 1982; 42: 747-753
46. Pedersen H, Hansen HS, Cederqvist C, Lober J. The prognostic significance of weight loss and its integration in stage-grouping of oesophageal cancer. Acta Chir Scand 1982; 148: 363-366
47. Fein R, Kelsen DP, Geller N, Bains M, McCormack P, Brennan MF. Adenocarcinoma of the esophagus and gastroesophageal junction. Cancer 1985; 56: 2512-2518
48. Coates RJ, Clark WS, Eley JW, Greenberg RS, Huguley CM, Brown RL. Race, nutritional status and survival from breast cancer. J Natl Cancer Inst 1990; 82: 1684-1692
49. van Bokhorst-de van der Schueren MAE, van Leeuwen PAM, Kuik DJ et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 1999; 86: 519-527
50. Ollenschläger G, Thomas W, Konkol K, Diehl V, Roth E. Nutritional behaviour and quality of life during oncological polychemotherapy: results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia. Eur J Clin Invest 1992; 22: 546-553
51. Bruning PF, Egger RJ, Gooskens AC et al. Dietary intake, nutritional status and well-being of cancer patients: a prospective study. Eur J Cancer 1985; 21: 1449-1459
52. Padilla GV. Psychological aspects of nutrition and cancer. Surg Clin North Am 1986; 66: 1121-1135
53. Fietkau R. Principles of feeding cancer patients via enteral or parenteral nutrition during radiotherapy. Strahlentherapie und Onkologie 1998; 174: 47-51
54. Ovesen L, Allingstrup L, Hannibal E, Mortensen EL, Hansen P. Effect of dietary counseling on food intake body weight, response rate, survival and quality of life in cancer patients undergoing chemotherapy: a prospective randomized study. J Clin Oncol 1993; 11: 2043-2049
55. Edington J, Winter PD, Coles SJ, Gale CR, Martyn CN. Outcomes of undernutrition in patients in the community with cancer or cardiovascular disease. Proc Nutr Soc 1999; 58: 655-661
56. Warren S. The immediate causes of death in cancer. Am J Med Sci 1932; 184: 610-615
57. Aslani A, Smith RC, Allen BJ, Paviakis N, Levi JA. The predictive value of body protein for chemotherapy-induced toxicity. Cancer 2000; 88: 796-803
58. Anonymous. American Gastroenterological Association medical position statement: parenteral nutrition. Gastroenterology 2001; 121: 966-969
59. Sax HC, Souba WW. Enteral and parenteral feedings. Guidelines and recommendations. Med Clin North Am 1993; 77: 863-880
60. ASPEN Board of Directors, Clinical Guidelines Task Force. Indications for specialized nutrition support. JPEN 2002; 26: 18SA-20SA
61. Brennan MF, Ekman L. Metabolic consequences of nutritional support of the cancer patient. Cancer 1984; 54: 2627-2634
62. Bodoky A, Dupont V, Heberer M, Harder F. Heimenterale Ernährung über Jejunostomiekatheter. Helvetica Chirurgica Acta 1990; 57: 141-146
63. Campos AC, Butters M, Meguid MM. Home enteral nutrition via gastrostomy in advanced head and neck cancer patients. Head & Neck 1990; 12: 137-142
64. Klein S, Koretz RL. Nutrition support in patients with cancer: What do the data really show? Nutr Clin Pract 1994; 9: 91-100
65. Mercadante S. Parenteral versus enteral nutrition in cancer patients: indications and practice. Supp Care Cancer 1998; 6: 85-93
66. Evans WK, Nixon DW, Daly JM et al. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer. J Clin Oncol 1987; 5: 113-124
67. Ovesen L, Allingstrup L. Different quantities of two commercial liquid diets consumed by weigh-losing cancer patients. JPEN 1992; 16: 275-278
68. Lee JH, Machtay M, Unger LD et al. Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998; 124: 871-875
69. Bozzetti F, Cozzaglio L, Gavazzi C et al. Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival. Tumori 1998; 84: 681-686
70. Fietkau R, Iro H, Sailer D, Sauer R. Percutaneous endoscopically guided gastrostomy in patients with head and neck cancer. Recent Results Cancer Res 1991; 121: 269-282
71. Ottery FD, Walsh D, Strawford A. Pharmacologic management of anorexia/cachexia. Sem Oncol 1998; 25: 35-44
72. Strang P. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (Review). Anticaner Res 1997; 17: 657-662
73. McMillan DC, O'Gorman P, Fearon KCH, McArdle CS. A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients. Br J Cancer 1997; 76: 788-790
74. Simons JPFHA, Schols AM, Hoefnagels JMJ, Westerterp KR, tenVelde GPM, Wouters EF. Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer. Cancer 1998; 82: 553-560
75. Fietkau R, Riepl M, Kettner H, Hinke A, Sauer R. Supportive Behandlung mit Megestrolacetat während der Radio-(Chemo-)Therapie bei Patienten mit Tumoren im Kopf-Hals-Bereich. Strahlentherapie und Onkologie 1996; 172: 162-168
76. Bruera E, Macmillan K, Kuehn N, Hanson J, MacDonald RN. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 1990; 66: 1279-1282
77. McMillan DC, Simpson JM, Preston T et al. Effect of megestrol acetate on weight loss, body composition and blood screen of gastrointestinal cancer patients. Clin Nutr 1994; 13: 85-89
78. Maltoni M, Nanni O, Scarpi E, Rossi D, Serra P, Amadori D. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. Ann Oncol 2001; 12: 289-300
79. Loprinzi CL, Kugler JW, Sloan JA et al. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 1999; 17: 3299-3306
80. Wigmore SJ, Ross JA, Falconer JS et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 1996; 12: 27-30
81. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KCH. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 1999; 81: 80-86
82. Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KCH. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer 2000; 36: 177-184
83. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy. Cancer 1998; 82: 395-402
84. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, DiCarlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002; 122: 1763-1770
85. van Bokhorst-de van de Schueren MAE, Quak JJ, von Blomberg-van der Flier ME et al. Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients. Am J Clin Nutr 2001; 73: 323-332
86. Daly JM, Weintraub FN, Shou J, Rosato EF, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995; 221: 327-338
87. Thiel HJ, Fietkau R, Sauer R. Malnutrition and the role of nutritional support for radiation therapy patients. Recent Results Cancer Res 1988; 108: 205-226
88. Collins MM, Wight RG, Partridge G. Nutritional consequences of radiotherapy in early laryngeal carcinoma. Ann Royal Coll Surg 1999; 81: 376-381
89. Arnold C, Richter MP. The effect of oral nutritional supplements on head and neck cancer. Int J Radiat Oncol Biol Phys 1989; 16: 1595-1599
90. Nayel H, el-Ghoneimy E, el-Haddad S. Impact of nutritional supplementation on treatment delay and morbidity in patients with head and neck tumours treated with irradiation. Nutrition 1992; 8: 13-18
91. Marcy PY, Magné N, Bensadoun RJ et al. Systematic percutaneous fluoroscopic gastrostomy for concomitant radiochemotherapy of advanced head and neck cancer: optimization of therapy. Supp Care Cancer 2000; 8: 410-413
92. Tyldesley S, Sheehan F, Munk P et al. The use of radiologically placed gastrostomy tubes in head and neck cancer patients receiving radiotherapy. Int J Radiat Oncol Biol Phys 1996; 36: 1205-1209
93. Öhrn KEO, Wahlin YB, Sjöden PO. Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications. Supp Care Cancer 2001; 9: 247-257
94. Mekhail TM, Adelstein DJ, Rybicki LA, Larto MA, Saxton JP, Lavertu P. Enteral nutrition during the treatment of head and neck carcinoma. Cancer 2001; 91: 1785-1790
95. Lees J. Nasogastric and percutaneous endoscopic gastrostomy feeding in head and neck cancer patients receiving radiotherapy treatment at a regional oncology unit: a two year study. Eur J Cancer Care 1997; 6: 45-49
96. Roberge C, Tran M, Massoud C et al. Quality of life and home enteral tube feeding: a French prospective study in patients with head and neck or oesophageal cancer. BrJ Cancer 2000; 82: 263-269
97. Weisdorf SA, Lysne J, Wind D et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation 1987; 43: 833-838
98. Herrmann VM, Petruska PJ. Nutrition support in bone marrow transplant recipients. Nutr Clin Pract 1993; 8: 19-27
99. Szeluga DJ, Stuart RK, Brookmeyer R, Utermohlen V, Santos GW. Nutritional support of bone marrow transplant recipients: a prospective, randomised clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res 1987; 47: 3309-3316
100. Roberts SR, Miller JE. Success using PEG tubes in marrow transplant recipients. Nutr Clin Pract 1998; 13: 74-78
101. Anderson PM, Ramsay NK, Shu XO et al. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant 1998; 22: 339-344
102. Schloerb PR, Skikne BS. Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study. JPEN 1999; 23: 117-122
103. Coghlin-Dickson TM, Wong RM, Offrin RS et al. Effect of oral glutamine supplementation during bone marrow transplantation. JPEN 2000; 24: 61-66
104. Bozzetti F. Is enteral nutrition a primary therapy in cancer patients? Gut 1994; 35: S65-S68
105. Rabeneck L, McCullough LB, Wray NP. Ethically justified, clinically comprehensive guidelines for percutaneous endoscopic gastrostomy tube placement. Lancet 1997; 349: 496-498
106. Löser C, Müller MJ. Ethische Richtlinien zur Anlage einer perkutan endoskopischen Gastrostomie (PEG-Sonde). Zschr Gastroenterol 1998; 36: 475-478
107. Bozzetti F. Effects of artificial nutrition on the nutritional status of cancer patients. JPEN 1989; 13: 406-420
108. Sartori S, Trevisani L, Tassinari D et al. Cost analysis of long-term feeding by percutaneous endoscopic gastrostomy in cancer patients in an Italian health district. Supp Care Cancer 1996; 4: 21-26
109. Lindh A, Cedermark B, Blomgren H, Wassermann J, Petrini B. Enteral and parenteral nutrition in anorectic patients with advanced gastrointestinal cancer. J Surg Oncol 1986; 33: 61-65